![]() More than 50 years ago, Medtronic invented SCS for pain management and continues to produce innovative breakthroughs that personalize care and enhance patient pain relief. This most recent generation of rechargeable neurostimulators represents a substantial advancement in SCS therapy and a turning point in contemporary neuromodulation. The Inceptiv closed-loop function will enable more optimal and consistent therapy delivery and less manual programming adjustment on the part of the patient. ![]() The distance between the spinal cord and the implanted epidural leads can change due to patient movements, which are not considered by fixed-output spinal cord stimulation today. The device can respond to patient movements in real time thanks to ECAPs, which directly measure how much neural tissue in the spinal cord is active in response to electrical stimulation. The Inceptiv device uses a closed-loop ECAP (Evoked Compound Action Potential) capacity, the result of years of research and development by Medtronic, to provide the ability to hear and react to signals throughout the spinal cord. Inceptiv SCS System is the first Medtronic SCS device to offer a closed-loop feature that senses each person's unique biological signals and adjusts stimulation moment to moment to keep therapy in sync with the motions of daily life. The latest approval will fortify Medtronic’s Neuromodulation business, part of the Neuroscience Portfolio. ![]() The Inceptiv SCS system won't be sold or distributed in the United States but will be commercially available in Europe in the upcoming months. Medtronic plc MDT recently received CE Mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |